The Neuron Specific Enolase ELISA (NSE ELISA) is intended for the quantitative determination of human neuron specific enolase (NSE) levels in serum samples. The Neuron Specific Enolase ELISA (NSE ELISA) might be used as an aid in researching neuronendocrine differentiated tumors such as small cell lung cancer and neuroblastoma, melanoma, seminoma; and with injury of the central nervous system such as traumatic brain injury (TBI).
Research Use Only. Not for Use in Diagnostic Procedures.
The glycolytic enzyme enolase (2-phospho-D-glycerate hydro-lyase) exists as several dimeric
isoenzymes (αα, αβ, ββ and γγ) composed of three distinct subunits: α, β, and γ. Three isoenzymes are found in the human brain: αα, αβ, and γγ. The heterologous αγ-isoenzyme and the
homologous γγ-enolase isoenzymes are known as neuron-specific enolase (NSE) as these
isoenzymes initially were detected in neurons and neuroendocrine cells. This assay detects both
the αγ and the γγ forms by using monoclonal antibodies specific to the γ-subunit of the enzyme.
Research demonstrates that NSE may be a valuable tumor biomarker of neuroendocrine origin,
particularly in small cell lung cancer and in neuroblastoma.
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.
Complement System Solutions for Drug Development and Clinical Research Datasheet
The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.
Melatonin Products for Sleep Disorder-Related Research Datasheet
The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.